The statins are a class of pharmaceuticals that act by competitively inhibiting 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase. The reductase is an enzyme involved in the liver cholesterol synthesis. The drugs are the most potent cholesterol lowering agents (LDL-cholesterol), however, they are less effective than the fibrates in reducing triglycerides and raising HDL-cholesterol. The statins play an important role in primary and secondary prevention of ischaemic heart disease and myocardial infarct.

There is ongoing research for other actions of statins apart from lipid-lowering for instance - anti-inflammatory or anti-dementive.

The statins are (brand names in countries other than the US can be different):

  • atorvastatin (Lipitor®)
  • fluvastatin (Lescol®)
  • lovastatin (Mevacor®, Altocor®)
  • pravastatin (Pravachol®)
  • rosuvastatin (Crestor®)
  • simvastatin (Zocor®)
  • cerivastatin (Lipobay®) - marketing discontinued due to serious side-effects

See also - References:
  1. FDA approval of rosuvastatin